Shan Jiang

机构：Minzu University of China, Huashan Hospital · ORCID：0000-0003-4377-4332

发表论文 231 篇 · 总被引 5025 次 · h-index 28

代表论文

• Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinoma (2024 · Pharmacological Research · 被引 14)
• Efficacy and safety of selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors in FGFR-altered urothelial carcinoma (2024 · Pharmacological Research · 被引 11)
• Involvement of interferon γ-producing mast cells in immune responses against melanocytes in vitiligo requires Mas-related G protein-coupled receptor X2 activation (2024 · Chinese Medical Journal · 被引 10)
• The influence of the gut microbiota on B cells in autoimmune diseases (2025 · Molecular Medicine · 被引 9)
• Increased splicing of CXCR3 isoform B (CXCR3B) by impaired NRF2 signaling leads to melanocyte apoptosis in active vitiligo (2024 · Free Radical Biology and Medicine · 被引 7)
• FGFR3 alteration sites and response rate to FGFR inhibitors in urothelial carcinoma (2025 · Pharmacological Research · 被引 4)